Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Protection of renal function in diabetics].

C Hasslacher1

  • 1St. Josefskrankenhaus Heidelberg, Akademisches Lehrkrankenhaus der Universität Heidelberg. C.Hasslacher@st.josefskrankenhaus.de

Der Internist
|June 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetic kidney disesase.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2014
Same author

The role of hypertension in diabetic nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2013
Same author

Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2010
Same author

[Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].

Deutsche medizinische Wochenschrift (1946)·2007
Same author

[Severe hypoglycemia in diabetics with impaired renal function].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

The influence of the ACE inhibitor lisinopril on the glomerular metabolism of proteolytic enzymes in diabetic rats.

Acta diabetologica·2001

Managing diabetic nephropathy involves controlling blood glucose and blood pressure. Early intervention with renin-angiotensin system blockers and lifestyle changes can prevent or slow kidney disease progression in diabetic patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Diabetic nephropathy is a major complication of diabetes mellitus.
  • Several factors influence its progression, offering therapeutic targets.

Purpose of the Study:

  • To outline primary and secondary prevention strategies for diabetic nephropathy.
  • To emphasize multifactorial therapeutic approaches for managing kidney disease in diabetics.

Main Methods:

  • Review of current evidence on managing diabetic nephropathy.
  • Focus on metabolic control (HbA1c), blood pressure management (RAS-blocking agents), and lifestyle modifications.
  • Consideration of drug pharmacokinetics in renal insufficiency.

Main Results:

Related Experiment Videos

  • Near-normal metabolic control at diabetes diagnosis reduces microalbuminuria risk.
  • Consistent treatment with RAS-blocking agents is crucial for hypertensive diabetics.
  • Multifactorial therapy, including blood pressure control and metabolic management, can halt or slow nephropathy progression.

Conclusions:

  • Effective management of diabetic nephropathy requires a multifactorial approach.
  • Early and consistent intervention targeting metabolic control, blood pressure, and other risk factors is essential.
  • Regular monitoring of kidney function and therapeutic adherence is critical.